Pharminent

FDA clears rival diabetes combos from Sanofi and Novo Nordisk

Xultophy set to launch in first half of 2017 while Soliqua is intended for January roll-out http://www.pmlive.com/pharma_news/fda_clears_rival_diabetes_combos_from_sanofi_and_novo_nordisk_1177910

Filed under: Diabetes